🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOrforglipron and hepatic first-pass metabolism — anyone have experience? Page 7

Orforglipron and hepatic first-pass metabolism — anyone have experience?

Dr.EM_Chicago Fri, Jan 31, 2025 at 6:59 PM 44 replies 1,967 viewsPage 7 of 9
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Feb 21, 2025 at 2:27 PM#31
Dr.EM_Chicago said:
What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and…

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

Happy to go further on any of that.

5 3VendorMark, COA_Karl, MikeFit_NJ and 2 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Feb 23, 2025 at 1:18 AM#32
Dr.EM_Chicago said:
What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and…

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

6 4TomTeleRx, DoseLogDan, SleepFixSam and 3 others
Reply Quote Save Share Report
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Feb 24, 2025 at 12:09 PM#33
Dr.EM_Chicago said:
What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and…

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

7 5SleepFixSam, PurityPaulOR, MaxMetOK and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Feb 25, 2025 at 10:59 PM#34

From the other side of the consultation, briefly. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

8 6labquiet_amy, emily_PDX, Dr.SleepRoch and 5 others
Reply Quote Save Share Report
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Feb 27, 2025 at 9:48 AM#35
CarlaRPh_TPA said:
It is worth asking what the claim would look like if it were false.

Same experience, arrived at from the opposite direction. Nothing to add that would improve it.

9 7bbq_ray_KC, oliver_london, tane_welly and 6 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register